SCHEMBL1906572

SCHEMBL1906572

CCC(C)(C)CI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1978409 0.79
SCHEMBL57088 0.74
SCHEMBL13352050 0.72 CYP2D6 (0.38)
SCHEMBL16622888 0.72
SCHEMBL12292439 0.72
Ammonia Solution, Strong SCHEMBL8081457 0.70
SCHEMBL8359826 0.70 TSHR (0.50)
Ammonia Solution, Strong SCHEMBL11315539 0.70
SCHEMBL22764 0.69
SCHEMBL103627 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230135188-A1 FE/CU-MEDIATED KETONE SYNTHESIS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2023-05-04 US disclosed
CN-108289886-A Ion channel inhibiting compound, pharmaceutical preparation and purposes 安华赛公司 2018-07-17 CN disclosed
EP-3340988-A1 ION CHANNEL INHIBITORY COMPOUNDS, PHARMACEUTICAL FORMULATIONS AND USES Afasci, Inc. (US) 2018-07-04 EP disclosed
US-9698250-B2 Method for the surface etching of a three-dimensional structure COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2017-07-04 US disclosed
WO-2017083867-A1 ION CHANNEL INHIBITORY COMPOUNDS, PHARMACEUTICAL FORMULATIONS AND USES AFASCI, INC. (US) 2017-05-18 WO disclosed
US-20160095858-A1 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator VERTEX PHARMACEUTICALS INCORPORATED (US) 2016-04-07 US disclosed
CN-102659683-B Process for production of 5-alkoxy-4-hydroxymethylpyrazole compound IHARA CHEMICAL IND CO 2014-11-12 CN disclosed
WO-2014025993-A1 INHIBITORS OF D-AMINO ACID OXIDASE THE JOHNS HOPKINS UNIVERSITY (US) 2014-02-13 WO disclosed
US-8580266-B2 Immune modulation via C-type lectin CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2013-11-12 US disclosed
CN-102659683-A Process for production of 5-alkoxy-4-hydroxymethylpyrazole compound IHARA CHEMICAL IND CO 2012-09-12 CN disclosed
CN-101384556-B Process for producing 5-alkoxy-4-hydroxymethylpyrazole compound IHARA CHEMICAL IND CO 2012-06-20 CN disclosed
WO-2011056652-A1 IMIDAZOLE DERIVATIVES AS IDO INHIBITORS NEWLINK GENETICS (US) 2011-05-12 WO disclosed
EP-1847556-B1 POLYMER, CROSSLINKED POLYMER, COMPOSITION FOR SOLID POLYMER ELECTROLYTE, SOLID POLYMER ELECTROLYTE AND ADHESIVE COMPOSITION NIPPON SODA CO (JP) 2010-12-08 EP disclosed
US-20100187472-A1 RECOVERY OF ORGANIC ACIDS ZEACHEM, INC. (US) 2010-07-29 US disclosed
EP-2199844-A1 PLASTIC LENS MANUFACTURING METHOD Hoya Corporation (JP) 2010-06-23 EP disclosed
WO-2009073505-A2 METHODS FOR PROCESSING TANDEM MASS SPECTRAL DATA FOR PROTEIN SEQUENCE ANALYSIS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2009-06-11 WO disclosed
WO-2009032177-A1 PHOSPHADIAZINE HCV POLYMERASE INHIBITORS I AND II IDENIX PHARMACEUTICALS, INC. (US) 2009-03-12 WO disclosed
WO-2009032179-A1 PHOSPHADIAZINE HCV POLYMERASE INHIBITORS III AND VI IDENIX PHARMACEUTICALS, INC. (US) 2009-03-12 WO disclosed
WO-2008144500-A2 1-METHYL-BENZO[1,2,4]THIADIAZINE, 1-OXIDE DERIVATIVES ANADYS PHARMACEUTICALS, INC. (US) 2008-11-27 WO disclosed
WO-2005019191-A2 1, 1-DIOXIDO-4H-1,2,4-BENZOTHIADIAZINE DERIVATE UND VERWANDTE VERBINDUNGEN ALS INHIBITOREN DER HCV POLYMERASE ZUR BEHANDLUNG VON HEPATITIS C ABBOTT LABORATORIES (US) 2005-03-03 WO disclosed